{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:31:28Z","timestamp":1795084288560,"version":"4.10.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3780,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1523-1755.2005.00460.x","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T18:03:59Z","timestamp":1121191439000},"page":"802-812","source":"Crossref","is-referenced-by-count":164,"title":["Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy"],"prefix":"10.1016","volume":"68","author":[{"given":"Sydney","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta Y.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hoi","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S.O.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Hang","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiu Wing","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar Neng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A controlled trial of fish oil in IgA nephropathy","volume":"331","author":"Donadio","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ndt\/5.4.241","article-title":"The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis","volume":"5","author":"Cheng","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0025","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1681\/ASN.V8111739","article-title":"Fish oil therapy for IgA nephropathy: Efficacy and interstudy variability","volume":"8","author":"Dillon","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.1996.116","article-title":"Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy","volume":"49","author":"Lai","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)","volume":"10","author":"Allison","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0040","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","author":"European Mycophenolate Mofetil Cooperative Study Group","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(05)60198-5","article-title":"Mycophenolate mofetil for systemic vasculitis and IgA nephropathy","volume":"349","author":"Nowack","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.V82199","article-title":"Predicting renal outcome in IgA nephropathy","volume":"8","author":"Radford","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","article-title":"Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases","volume":"29","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0272-6386(00)70191-0","article-title":"Outcome of IgA nephropathy in adults graded by chronic histological lesions","volume":"35","author":"To","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.V10169","article-title":"Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells","volume":"10","author":"Tang","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0075","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1523-1755.2002.00301.x","article-title":"Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: Implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria","volume":"61","author":"Tang","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI16079","article-title":"Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo","volume":"111","author":"Tang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0085","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.V8101537","article-title":"Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein","volume":"8","author":"Wang","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0272-6386(96)90512-0","article-title":"The role of proteinuria in the progression of chronic renal failure","volume":"27","author":"Burton","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0100","first-page":"F457","article-title":"ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy","volume":"276","author":"Remuzzi","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0105","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"The Gisen Group (Gruppo Italiano Di Studi Epidemiologici In Nefrologia)","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1523-1755.2001.00489.x","article-title":"Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy","volume":"59","author":"Leung","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0115","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ndt\/16.9.1752","article-title":"Mycophenolate mofetil: Implications for the treatment of glomerular disease","volume":"16","author":"Badid","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0120","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000063294","article-title":"Future directions in the treatment of IgA nephropathy","volume":"92","author":"Lai","year":"2002","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0130","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","article-title":"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study","volume":"65","author":"Maes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0135","first-page":"796","article-title":"[A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy]","volume":"82","author":"Chen","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0140","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/ndt\/12.12.2569","article-title":"IgA nephropathy: Prognostic classification of end-stage renal failure. L'Association des Nephrologues de l'Est","volume":"12","author":"Frimat","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/ajkd.2002.30562","article-title":"Primary IgA nephropathy with low histologic grade and disease progression: Is there a \u201cpoint of no return\u201d?","volume":"39","author":"Lai","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.V112283","article-title":"Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney","volume":"11","author":"Fujihara","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0155","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1681\/ASN.V104804","article-title":"Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease","volume":"10","author":"Abbate","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0160","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0165","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0170","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","article-title":"Idiopathic membranous nephropathy: Definition and relevance of a partial remission","volume":"66","author":"Troyanov","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0175","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1046\/j.1523-1755.2002.00380.x","article-title":"Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts","volume":"61","author":"Abbate","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0180","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1523-1755.2004.00958.x","article-title":"Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells","volume":"66","author":"Wolf","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0185","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D'Amico","year":"1987","journal-title":"Q J Med"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-5-3","article-title":"A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN6257616]","volume":"5","author":"Hogg","year":"2004","journal-title":"BMC Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/ajkd.2002.34882","article-title":"Mycophenolate mofetil in lupus glomerulonephritis","volume":"40","author":"Mok","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jcla.2035","article-title":"Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy","volume":"16","author":"Leung","year":"2002","journal-title":"J Clin Lab Anal"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/18.1.36","article-title":"Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy","volume":"18","author":"Leung","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000422410","article-title":"Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy","volume":"104","author":"Mestecky","year":"1993","journal-title":"Contrib Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0215","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.79.20.6229","article-title":"IgA interaction with the asialoglycoprotein receptor","volume":"79","author":"Stockert","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ki.1990.193","article-title":"Interleukin 6 is an autocrine growth factor for mesangial cells","volume":"38","author":"Ruef","year":"1990","journal-title":"Kidney Int"},{"issue":"Suppl","key":"10.1111\/j.1523-1755.2005.00460.x_bb0225","first-page":"S71","article-title":"Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis","volume":"39","author":"Horii","year":"1993","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0230","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1998.00745.x","article-title":"Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy?","volume":"114","author":"Rostoker","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08916939309019924","article-title":"Increased interleukin 6 mRNA expression by peripheral blood T cells from patients with IgA nephropathy","volume":"15","author":"Nakamura","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000064297","article-title":"Effect of mizoribine on IL-6 release by peripheral blood mononuclear cells","volume":"91","author":"Kaneko","year":"2002","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1328-8067.2001.01532.x","article-title":"Mizoribine treatment for childhood IgA nephropathy","volume":"44","author":"Nagaoka","year":"2002","journal-title":"Pediatr Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000044994","article-title":"Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice","volume":"79","author":"Shimizu","year":"1998","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0255","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1681\/ASN.V1071542","article-title":"Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals","volume":"10","author":"Remuzzi","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1755.2000.00140.x","article-title":"Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney","volume":"58","author":"Badid","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00460.x_bb0265","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","article-title":"Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion","volume":"14","author":"Hauser","year":"1999","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815509022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815509022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T13:12:35Z","timestamp":1735823555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815509022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0085253815509022"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00460.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}